A Rare Case of Spontaneous Bladder Rupture in a Herpes Zoster Patient.
Huang J, Tai S, Ding H, Xu L, Hua R, Yu Y, Mao D.
Infect Drug Resist. 2022 Sep 5;15:5193-5196. doi: 10.2147/IDR.S380752. eCollection 2022.
Oncolytic virus therapy: A new era of cancer treatment at dawn.
Fukuhara H, Ino Y, Todo T.
Cancer Sci. 2016 Oct;107(10):1373-1379. doi: 10.1111/cas.13027. Epub 2016 Sep 9.
Role of human papillomavirus and associated viruses in bladder cancer: An updated review.
Yao X, Xu Z, Duan C, Zhang Y, Wu X, Wu H, Liu K, Mao X, Li B, Gao Y, Xu H, Wang X.
J Med Virol. 2023 Sep;95(9):e29088. doi: 10.1002/jmv.29088.
Association of human herpes, papilloma and polyoma virus families with bladder cancer.
Panagiotakis GI, Papadogianni D, Chatziioannou MN, Lasithiotaki I, Delakas D, Spandidos DA.
Tumour Biol. 2013 Feb;34(1):71-9. doi: 10.1007/s13277-012-0512-2. Epub 2012 Sep 13.
Effects of herpes simplex virus vector-mediated enkephalin gene therapy on bladder overactivity and nociception.
Yokoyama H, Oguchi T, Goins WF, Goss JR, Nishizawa O, de Groat WC, Wolfe D, Krisky DM, Glorioso JC, Yoshimura N.
Hum Gene Ther. 2013 Feb;24(2):170-80. doi: 10.1089/hum.2011.180. Epub 2013 Feb 14.
Oncolytic Viruses for the Treatment of Bladder Cancer: Advances, Challenges, and Prospects.
Hu H, Xia Q, Hu J, Wang S.
J Clin Med. 2022 Nov 26;11(23):6997. doi: 10.3390/jcm11236997.
The effect of herpes simplex virus vector-mediated gene therapy of protein phosphatase 1alpha on bladder overactivity and nociception.
Majima T, Mori K, Kadekawa K, Takai S, Funahashi Y, Reinhart B, Goins WF, Gotoh M, Glorioso JC, Yoshimura N.
Neurourol Urodyn. 2019 Feb;38(2):582-590. doi: 10.1002/nau.23882. Epub 2018 Nov 29.
Herpes Simplex Virus Vector-Mediated Gene Delivery of Poreless TRPV1 Channels Reduces Bladder Overactivity and Nociception in Rats.
Majima T, Funahashi Y, Takai S, Goins WF, Gotoh M, Tyagi P, Glorioso JC, Yoshimura N.
Hum Gene Ther. 2015 Nov;26(11):734-42. doi: 10.1089/hum.2015.026. Epub 2015 Aug 31.
Effect of herpes simplex virus vector-mediated interleukin-4 gene therapy on bladder overactivity and nociception.
Oguchi T, Funahashi Y, Yokoyama H, Nishizawa O, Goins WF, Goss JR, Glorioso JC, Yoshimura N.
Gene Ther. 2013 Feb;20(2):194-200. doi: 10.1038/gt.2012.24. Epub 2012 Mar 8.
Infection: is it a cause of bladder cancer?
Abol-Enein H.
Scand J Urol Nephrol Suppl. 2008 Sep;(218):79-84. doi: 10.1080/03008880802325309.
